Specific subsets of CAFs in breast cancer were found to retain CD4+ CD25+ T cells at their surfaces through OX40L, PD-L2, and junctional adhesion molecule 2 pathways to promote their differentiation into Tregs through B7H3 (CD276), CD73, and dipeptidyl-peptidase 4. This evidence concerns the gene CD276 and breast cancer.